CERO THERAPEUTICS HOLDINGS I (CERO) Stock Cash Flow
NASDAQ:CERO - Nasdaq - US71902K1051 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -9.26M | -2.54M | -667.70K | -315.60K | |||
| Change In Working Capital | 805.80K | 1.50M | 2.41M | -382.00K | |||
| Taxes Paid | N/A | 670.40K | N/A | 16.90K | |||
| Other non cash items | -3.45M | -491.60K | -2.84M | 400.00 | |||
| OPERATING CASH FLOW | -11.56M | -1.52M | -1.09M | -697.10K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Other Investing Activity | -13.82M | -7.94M | 180.84M | -178.50M | |||
| INVESTING CASH FLOW | -13.82M | -7.94M | 180.84M | -178.50M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | 267.81K | 905.00K | 650.00K | 0.00 | |||
| Stock Issued/Repurchased | -15.69M | -33.48M | -139.35M | 172.39M | |||
| Other Financing Activity | N/A | N/A | N/A | 7.91M | |||
| FINANCING CASH FLOW | -15.44M | -32.58M | -138.70M | 180.30M | |||
| CHANGE IN CASH | -40.82M | -42.04M | 41.04M | 1.10M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -11.56M | -1.52M | -1.09M | -697.10K | |||
| FREE CASH FLOW | -11.56M | -1.52M | -1.09M | -697.10K | |||
All data in USD